Market Overview

Oncolytics Closes Offering of 8M Shares at $4/Share for Gross Proceeds of $32M

Share:
Related ONCY
US Stock Futures Up Ahead Of Consumer Credit Report
Oncolytics Biotech Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Gastric Cancer

Oncolytics Biotech Inc. (NASDAQ: ONCY) announced today that it has closed its previously announced underwritten public offering of 8.0 million common shares, at a public offering price of US$4.00 per common share.  The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Oncolytics, were approximately US$32.0 million.

Posted-In: News Offerings

 

Related Articles (ONCY)

Around the Web, We're Loving...